16:02 Dec 20
Laurus Labs Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Laurus Labs Ltd.
39/100 Medium Financial Strength
Quality16/100 Expensive Valuation
Valuation63/100 Technically Moderately Bullish
TechnicalSWOT
Strength
5
Weakness
11
Opportunity
1
Threat
1
30.15K
Market Cap (Cr)
229.98
PE Ratio
7.29
Price to Book Ratio
54.97
RSI
3.18 %
Net Profit Margin
Rating Based on 4 Analysts
Buy
25%
Hold
50%
Sell
25%
Hold
Analyst Price Target
The average price target is 445 with a high estimate of 530 and low estimate of 305
Current 559.20
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation
SWOT
Download Our App On:
